Leveraging selective knockdown of Sost gene by polyethyleneimine-siRNA-chitosan reduced gold nanoparticles to promote osteogenesis in MC3T3-E1 & MEF cells
Aim: Osteoporosis is a systemic skeletal disorder characterized by reduced osteoblast differentiation, predominantly by overexpression of the Sost gene. A layer-by-layer approach enabled encapsulation of Sost siRNA to enhance the short half-life and poor transfection capacity of siRNA. Materials & methods: Polyethyleneimine and siRNA on chitosan-coated gold nanoparticles (PEI/siRNA/Cs-AuNPs) were engineered using chitosan-reduced gold nanoparticles. They were characterized by dynamic light scattering, scanning electron microscopy, transmission electron microscopy, Fourier transform infrared and gel-mobility assays. Detailed in vitro experiments, gene silencing and western blots were performed. Results: A total of 80% knockdown of the target sclerostin protein was observed by PEI/siRNA/Cs-AuNPs, q-PCR showed threefold downregulation of the Sost gene. Osteogenic markers RunX2 and Alp were significantly upregulated. Conclusion: We report a safe, biocompatible nanotherapeutic strategy to enhance siRNA protection and subsequent silencing to augment bone formation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
---|---|
Enthalten in: |
Nanomedicine (London, England) - 19(2024), 10 vom: 19. Apr., Seite 895-914 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Niveria, Karishma [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 29.03.2024 Date Revised 22.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.2217/nnm-2023-0325 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370204646 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370204646 | ||
003 | DE-627 | ||
005 | 20240422232313.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240328s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2217/nnm-2023-0325 |2 doi | |
028 | 5 | 2 | |a pubmed24n1383.xml |
035 | |a (DE-627)NLM370204646 | ||
035 | |a (NLM)38530906 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Niveria, Karishma |e verfasserin |4 aut | |
245 | 1 | 0 | |a Leveraging selective knockdown of Sost gene by polyethyleneimine-siRNA-chitosan reduced gold nanoparticles to promote osteogenesis in MC3T3-E1 & MEF cells |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.03.2024 | ||
500 | |a Date Revised 22.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Aim: Osteoporosis is a systemic skeletal disorder characterized by reduced osteoblast differentiation, predominantly by overexpression of the Sost gene. A layer-by-layer approach enabled encapsulation of Sost siRNA to enhance the short half-life and poor transfection capacity of siRNA. Materials & methods: Polyethyleneimine and siRNA on chitosan-coated gold nanoparticles (PEI/siRNA/Cs-AuNPs) were engineered using chitosan-reduced gold nanoparticles. They were characterized by dynamic light scattering, scanning electron microscopy, transmission electron microscopy, Fourier transform infrared and gel-mobility assays. Detailed in vitro experiments, gene silencing and western blots were performed. Results: A total of 80% knockdown of the target sclerostin protein was observed by PEI/siRNA/Cs-AuNPs, q-PCR showed threefold downregulation of the Sost gene. Osteogenic markers RunX2 and Alp were significantly upregulated. Conclusion: We report a safe, biocompatible nanotherapeutic strategy to enhance siRNA protection and subsequent silencing to augment bone formation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a RT-PCR | |
650 | 4 | |a Sost siRNA | |
650 | 4 | |a gene silencing | |
650 | 4 | |a gold–chitosan nanoparticles | |
650 | 4 | |a osteogenic biomarkers | |
650 | 4 | |a osteoporosis | |
650 | 7 | |a Chitosan |2 NLM | |
650 | 7 | |a 9012-76-4 |2 NLM | |
650 | 7 | |a Gold |2 NLM | |
650 | 7 | |a 7440-57-5 |2 NLM | |
650 | 7 | |a Polyethyleneimine |2 NLM | |
650 | 7 | |a 9002-98-6 |2 NLM | |
650 | 7 | |a RNA, Small Interfering |2 NLM | |
650 | 7 | |a Sost protein, mouse |2 NLM | |
650 | 7 | |a Adaptor Proteins, Signal Transducing |2 NLM | |
700 | 1 | |a ZafarYab, Mohammad |e verfasserin |4 aut | |
700 | 1 | |a Biswas, Largee |e verfasserin |4 aut | |
700 | 1 | |a Mahtab, Asiya |e verfasserin |4 aut | |
700 | 1 | |a Verma, Anita Kamra |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nanomedicine (London, England) |d 2006 |g 19(2024), 10 vom: 19. Apr., Seite 895-914 |w (DE-627)NLM17228452X |x 1748-6963 |7 nnns |
773 | 1 | 8 | |g volume:19 |g year:2024 |g number:10 |g day:19 |g month:04 |g pages:895-914 |
856 | 4 | 0 | |u http://dx.doi.org/10.2217/nnm-2023-0325 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 19 |j 2024 |e 10 |b 19 |c 04 |h 895-914 |